These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
416 related articles for article (PubMed ID: 30337176)
1. Recommendations to control pertussis prioritized relative to economies: A Global Pertussis Initiative update. Forsyth KD; Tan T; von König CW; Heininger U; Chitkara AJ; Plotkin S Vaccine; 2018 Nov; 36(48):7270-7275. PubMed ID: 30337176 [TBL] [Abstract][Full Text] [Related]
2. Pertussis in Africa: Findings and recommendations of the Global Pertussis Initiative (GPI). Muloiwa R; Wolter N; Mupere E; Tan T; Chitkara AJ; Forsyth KD; von König CW; Hussey G Vaccine; 2018 Apr; 36(18):2385-2393. PubMed ID: 29602703 [TBL] [Abstract][Full Text] [Related]
3. Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles. van der Lee S; Hendrikx LH; Sanders EAM; Berbers GAM; Buisman AM Front Immunol; 2018; 9():51. PubMed ID: 29416544 [TBL] [Abstract][Full Text] [Related]
4. The Global Pertussis Initiative: meeting report from the fourth regional roundtable meeting, France, April 14-15, 2010. Guiso N; Liese J; Plotkin S Hum Vaccin; 2011 Apr; 7(4):481-8. PubMed ID: 21389775 [TBL] [Abstract][Full Text] [Related]
5. Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccination. van der Lee S; Sanders EAM; Berbers GAM; Buisman AM Vaccine; 2018 Jan; 36(2):220-226. PubMed ID: 29199041 [TBL] [Abstract][Full Text] [Related]
6. Pertussis immunization in the global pertussis initiative international region: recommended strategies and implementation considerations. Forsyth K; Nagai M; Lepetic A; Trindade E Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S93-7. PubMed ID: 15876935 [TBL] [Abstract][Full Text] [Related]
7. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV; MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217 [TBL] [Abstract][Full Text] [Related]
8. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. America Academy of Pediatrics Commitee on Infectious Diseases Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131 [TBL] [Abstract][Full Text] [Related]
9. Tdap5 vaccine (Covaxis): a review of its use as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis in children (aged 4 years), adolescents, and adults. Scott LJ BioDrugs; 2010 Dec; 24(6):387-406. PubMed ID: 21043546 [TBL] [Abstract][Full Text] [Related]
11. Pertussis vaccination in mixed markets: Recommendations from the Global Pertussis Initiative. Chitkara AJ; Pujadas Ferrer M; Forsyth K; Guiso N; Heininger U; Hozbor DF; Muloiwa R; Tan TQ; Thisyakorn U; Wirsing von König CH Int J Infect Dis; 2020 Jul; 96():482-488. PubMed ID: 32413606 [TBL] [Abstract][Full Text] [Related]
12. [Whooping cough in Spain. Current epidemiology, prevention and control strategies. Recommendations by the Pertussis Working Group]. Campins M; Moreno-Pérez D; Gil-de Miguel A; González-Romo F; Moraga-Llop FA; Arístegui-Fernández J; Goncé-Mellgren A; Bayas JM; Salleras-Sanmartí L Enferm Infecc Microbiol Clin; 2013 Apr; 31(4):240-53. PubMed ID: 23411362 [TBL] [Abstract][Full Text] [Related]
13. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age. Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247 [TBL] [Abstract][Full Text] [Related]
14. Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations. Bechini A; Tiscione E; Boccalini S; Levi M; Bonanni P Vaccine; 2012 Jul; 30(35):5179-90. PubMed ID: 22709953 [TBL] [Abstract][Full Text] [Related]
15. [Time for booster doses against whooping cough for 10-year-old children]. Carlsson RM; Ekholm L; Gothefors L; Granström M; Trolin I; Tegnell A Lakartidningen; 2005 Aug 29-Sep 4; 102(35):2394-8. PubMed ID: 16184889 [TBL] [Abstract][Full Text] [Related]
16. Which strategy for pertussis vaccination today? Girard DZ Paediatr Drugs; 2002; 4(5):299-313. PubMed ID: 11994035 [TBL] [Abstract][Full Text] [Related]
17. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep; 1997 Mar; 46(RR-7):1-25. PubMed ID: 9091780 [TBL] [Abstract][Full Text] [Related]
18. Pertussis vaccine effectiveness following country-wide implementation of a hexavalent acellular pertussis immunization schedule in infants and children in Panama. Calvo AE; Tristán Urrutia AG; Vargas-Zambrano JC; López Castillo H Hum Vaccin Immunother; 2024 Dec; 20(1):2389577. PubMed ID: 39164002 [TBL] [Abstract][Full Text] [Related]
19. Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination. Schure RM; Hendrikx LH; de Rond LG; Oztürk K; Sanders EA; Berbers GA; Buisman AM Clin Vaccine Immunol; 2013 Sep; 20(9):1388-95. PubMed ID: 23825195 [TBL] [Abstract][Full Text] [Related]
20. Pertussis control in the Asia-Pacific region: a report from the Global Pertussis Initiative. Forsyth K; Thisyakorn U; von König CH; Tan T; Plotkin S; Southeast Asian J Trop Med Public Health; 2012 May; 43(3):699-711. PubMed ID: 23077850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]